Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ROBIN KATHLEEN DORE

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1619972510
CMS profile
209026
Location
TUSTIN, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$327,784.58

532 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
Janssen Scientific Affairs, LLC $92,807.32 71
ABBVIE INC. $85,927.84 120
UCB, Inc. $45,497.40 65
Alexion Pharmaceuticals, Inc. $32,359.52 38
Lilly USA, LLC $22,571.99 46
Amgen Inc. $19,360.56 59
Horizon Therapeutics plc $7,952.69 26
AstraZeneca Pharmaceuticals LP $7,284.99 16
Novartis Pharmaceuticals Corporation $6,656.25 18
GlaxoSmithKline, LLC. $4,217.79 16
Radius Health, Inc. $2,161.87 11
Janssen Biotech, Inc. $569.00 27
Boehringer Ingelheim Pharmaceuticals, Inc. $190.94 8
Genentech USA, Inc. $53.37 3
GENZYME CORPORATION $48.11 1
PFIZER INC. $45.73 3
Alvogen Inc $31.64 2
Aurinia Pharma U.S., Inc. $29.00 1
E.R. Squibb & Sons, L.L.C. $18.57 1

Page 2 of 11; records 51–100 of 532 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ROBIN KATHLEEN DORE

NPI 1619972510 · CMS profile ID 209026

Allopathic & Osteopathic Physicians / Internal Medicine / Rheumatology

TUSTIN, CA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 11; records 51–100 of 532 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1619972510?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ROBIN KATHLEEN DORE, NPI 1619972510, CMS profile ID 209026. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 11; records 51–100 of 532 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1619972510?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). ROBIN KATHLEEN DORE, NPI 1619972510, CMS profile ID 209026. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 11; records 51–100 of 532 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1619972510?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
ROBIN KATHLEEN DORE, NPI 1619972510, CMS profile ID 209026, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 11; records 51–100 of 532 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1619972510?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

532 matching records · $327,784.58 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 532 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 532.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Radius Health, Inc. $23.4611/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954962659 CMS
Alexion Pharmaceuticals, Inc. $32.6311/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914640391 CMS
Alexion Pharmaceuticals, Inc. $144.4211/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915685743 CMS
Alexion Pharmaceuticals, Inc. $114.3011/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915786737 CMS
Janssen Scientific Affairs, LLC $69.7611/09/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887188977 CMS
Janssen Scientific Affairs, LLC $732.0011/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887188983 CMS
Janssen Scientific Affairs, LLC $1,357.3611/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887188989 CMS
Janssen Scientific Affairs, LLC $199.6611/09/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887188995 CMS
ABBVIE INC. $2,000.0011/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881777 CMS
ABBVIE INC. $2,800.0011/08/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881779 CMS
ABBVIE INC. $29.4111/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881781 CMS
Alexion Pharmaceuticals, Inc. $114.3011/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915507597 CMS
Alexion Pharmaceuticals, Inc. $144.4311/08/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915622121 CMS
Alexion Pharmaceuticals, Inc. $57.3011/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915646563 CMS
Amgen Inc. $10.4111/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939430951 CMS
ABBVIE INC. $10.1211/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881763 CMS
ABBVIE INC. $219.0011/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881765 CMS
ABBVIE INC. $65.0011/05/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881767 CMS
ABBVIE INC. $6.2311/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881769 CMS
ABBVIE INC. $114.3111/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881771 CMS
ABBVIE INC. $124.4811/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881773 CMS
ABBVIE INC. $99.1611/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881775 CMS
Alexion Pharmaceuticals, Inc. $16.0311/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915647147 CMS
Radius Health, Inc. $8.0911/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 954962666 CMS
ABBVIE INC. $339.2911/04/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881759 CMS
ABBVIE INC. $206.4311/04/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881761 CMS
ABBVIE INC. $1,490.8211/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881749 CMS
ABBVIE INC. $132.0211/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881751 CMS
ABBVIE INC. $610.2111/03/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881753 CMS
ABBVIE INC. $108.6111/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881755 CMS
ABBVIE INC. $18.0011/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881757 CMS
ABBVIE INC. $351.1011/02/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881745 CMS
ABBVIE INC. $264.0411/02/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881747 CMS
Novartis Pharmaceuticals Corporation $10.7311/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893607941 CMS
ABBVIE INC. $1,200.0011/01/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881739 CMS
ABBVIE INC. $16.4711/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881741 CMS
ABBVIE INC. $400.1911/01/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890881743 CMS
UCB, Inc. $41.1511/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907973391 CMS
Amgen Inc. $10.2710/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939430949 CMS
UCB, Inc. $1,110.0010/31/2022 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1038605929 CMS
Amgen Inc. $5.7110/28/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939430911 CMS
Alexion Pharmaceuticals, Inc. $2,000.0010/27/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 915488063 CMS
GlaxoSmithKline, LLC. $22.5410/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945056975 CMS
Alexion Pharmaceuticals, Inc. $22.2810/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914807719 CMS
Alexion Pharmaceuticals, Inc. $195.4310/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914877401 CMS
Alexion Pharmaceuticals, Inc. $195.4410/25/2022 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 914889483 CMS
Janssen Scientific Affairs, LLC $3,500.0010/25/2022 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 887188839 CMS
UCB, Inc. $9.5110/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 907973371 CMS
Horizon Therapeutics plc $0.7910/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937614859 CMS
Horizon Therapeutics plc $4.3310/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937614861 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $403,262.87 710
PY2020 $174,390.69 275
PY2021 $129,984.81 363
PY2022 $327,784.58 532
PY2023 $118,610.81 221
PY2024 $170,306.47 307
PY2025 $181,545.69 353

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $13,815.10 8
PY2022 Recipient $10,100.00 2
PY2022 Principal investigator $17,548.30 14
PY2021 Recipient $1,210.63 1
PY2021 Principal investigator $49,018.34 39
PY2020 Recipient $1,779.50 2
PY2020 Principal investigator $171,220.36 45
PY2019 Principal investigator $192,562.90 49

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $1,219.65 11/07/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate No dispute reported 06/30/2026 998406659
Principal investigator 1 ABBVIE INC. $490.05 07/11/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate No dispute reported 06/30/2026 998390183
Principal investigator 1 ABBVIE INC. $580.25 06/08/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate No dispute reported 06/30/2026 998386299
Principal investigator 1 ABBVIE INC. $8,466.00 05/03/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study to Compare Upadacitinib (ABT-494) to Placebo in Adults With Rheumatoid Arthritis on Stable Dose of Conventional Synthetic Disease-Modifying Antirheumatic Drugs (csDMARDs) With an Inadequate Response or Intolerance to Biologic DMARDs No dispute reported 06/30/2026 998380363
Principal investigator 1 ABBVIE INC. $877.00 04/13/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate No dispute reported 06/30/2026 998378513
Principal investigator 1 ABBVIE INC. $1,219.65 03/16/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate No dispute reported 06/30/2026 998374861
Principal investigator 1 ABBVIE INC. $764.50 02/09/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis No dispute reported 06/30/2026 998369691
Principal investigator 1 ABBVIE INC. $198.00 01/12/2023 Non-covered Recipient Entity
ROBIN K DORE MD
A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Adults With Rheumatoid Arthritis Who Are on a Stable Dose of Methotrexate and Who Have an Inadequate Response to Methotrexate No dispute reported 06/30/2026 998366023